Long-term effects of denosumab on bone mineral density and turnover markers in patients undergoing hemodialysis

被引:0
|
作者
Kazuhiko Kato
Tatsuhiro Yaginuma
Arisa Kobayashi
Akio Nakashima
Ichiro Ohkido
Takashi Yokoo
机构
[1] The Jikei University School of Medicine,Division of Nephrology and Hypertension, Department of Internal Medicine
[2] The Jikei University School of Medicine,Division of Molecular Epidemiology
[3] Keijin Hospital,Division of Nephrology
[4] Kyoto University Graduate School of Medicine,Human Health Sciences
来源
关键词
Bone mineral density; Bone turnover markers; Denosumab; Hemodialysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:264 / 270
页数:6
相关论文
共 50 条
  • [21] Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women
    Wensel, Terri M.
    Iranikhah, Maryam M.
    Wilborn, Teresa W.
    [J]. PHARMACOTHERAPY, 2011, 31 (05): : 510 - 523
  • [22] Effects of Denosumab on Bone Metabolic Markers and Bone Mineral Density in Patients Treated with Glucocorticoids
    Sawamura, Masato
    Komatsuda, Atsushi
    Togashi, Masaru
    Wakui, Hideki
    Takahashi, Naoto
    [J]. INTERNAL MEDICINE, 2017, 56 (06) : 631 - 636
  • [23] Assessment of bone mineral density and markers of bone turnover in children under long-term oral anticoagulant therapy
    Avgeri, Maria
    Papadopoulou, Anna
    Platokouki, Helen
    Douros, Kostas
    Rammos, Spyridon
    Nicolaidou, Polyxeni
    Aronis, Sophia
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2008, 30 (08) : 592 - 597
  • [24] Interrelationships between sarcopenia, bone turnover markers and low bone mineral density in patients on hemodialysis
    Wang, Yilin
    Ma, Wenxia
    Pu, Jianhong
    Chen, Fengling
    [J]. RENAL FAILURE, 2023, 45 (01)
  • [25] Correlation between Bone Turnover Markers and Bone Mineral Density in Patients Undergoing Long-Term Anti-Osteoporosis Treatment: A Systematic Review and Meta-Analysis
    Hong, Lingyun
    Liu, Dan
    Wu, Feng
    Wang, Meiqi
    Cen, Yu
    Ma, Lan
    [J]. APPLIED SCIENCES-BASEL, 2020, 10 (03):
  • [26] Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
    Bone, Henry G.
    Bolognese, Michael A.
    Yuen, Chui Kin
    Kendler, David L.
    Miller, Paul D.
    Yang, Yu-Ching
    Grazette, Luanda
    San Martin, Javier
    Gallagher, J. Christopher
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04): : 972 - 980
  • [27] Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
    M. Kamimura
    Y. Nakamura
    S. Ikegami
    S. Uchiyama
    H. Kato
    A. Taguchi
    [J]. Osteoporosis International, 2017, 28 : 559 - 566
  • [28] Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
    Kamimura, M.
    Nakamura, Y.
    Ikegami, S.
    Uchiyama, S.
    Kato, H.
    Taguchi, A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 (02) : 559 - 566
  • [29] Association of bone mineral density with biochemical markers of bone turnover in hemodialysis children
    Hajizadeh, Niloofar
    Mehrkash, Mehryar
    Fahimi, Daryoosh
    Qorbani, Mostafa
    Shafa, Nina
    [J]. JOURNAL OF RENAL INJURY PREVENTION, 2016, 5 (04): : 174 - 178
  • [30] Bone mineral density (BMD) and biochemical markers of bone remodeling in patients on long-term dialysis
    Leal, D
    Freundlich, M
    Levis, S
    Montane, B
    Abithol, C
    Strauss, J
    Gomez-Marin, O
    Zilleruelo, G
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 448A - 448A